Human Immunodeficiency Virus Type-1 Gag and Host Vesicular Trafficking Pathways

被引:29
|
作者
Chu, Hin [1 ]
Wang, Jaang-Jiun [1 ]
Spearman, Paul [1 ]
机构
[1] Emory Univ, Dept Pediat & Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA
来源
关键词
HIV-1 ENVELOPE GLYCOPROTEIN; TRANS-GOLGI NETWORK; TAIL-INTERACTING PROTEIN; MURINE LEUKEMIA-VIRUS; TYROSINE-BASED SIGNAL; PLASMA-MEMBRANE; MATRIX PROTEIN; MULTIVESICULAR BODY; LATE ENDOSOMES; INTRACELLULAR TRAFFICKING;
D O I
10.1007/978-3-642-02175-6_4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Gag protein of HIV-1 directs the particle assembly process. Gag recruits components of the cellular vesicular trafficking machinery in order to traverse the cytoplasm of the cell and reach the particle assembly site. The plasma membrane is the primary site of particle assembly in most cell types, while in macrophages an unusual intracellular membrane-bound compartment bearing markers of late endosomes and the plasma membrane is the predominant assembly site. Plasma membrane specificity of assembly may be directed by components of lipid rafts and the cytoplasmic leaflet component PI(4,5)P-2. Recent work has highlighted the role of adaptor protein complexes, protein sorting and recycling pathways, components of the multivesicular body, and cellular motor proteins in facilitating HIV assembly and budding. This review presents an overview of the relevant vesicular trafficking pathways and describes the individual components implicated in interactions with Gag.
引用
收藏
页码:67 / 84
页数:18
相关论文
共 50 条
  • [21] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [22] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ANTIGENEMIA IN CHILDREN
    BORKOWSKY, W
    KRASINSKI, K
    PAUL, D
    HOLZMAN, R
    MOORE, T
    BEBENROTH, D
    LAWRENCE, R
    CHANDWANI, S
    JOURNAL OF PEDIATRICS, 1989, 114 (06): : 940 - 945
  • [23] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [24] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [25] Molecular biology of human immunodeficiency virus type-1
    Joshi, S
    Joshi, RL
    TRANSFUSION SCIENCE, 1996, 17 (03): : 351 - 378
  • [26] Transgenic models of human immunodeficiency virus type-1
    Klotman, PE
    Notkins, AL
    TRANSGENIC MODELS OF HUMAN VIRAL AND IMMUNOLOGICAL DISEASE, 1996, 206 : 197 - 222
  • [27] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [28] ANALYSIS OF A RAPE CASE BY DIRECT SEQUENCING OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL AND GAG GENES
    ALBERT, J
    WAHLBERG, J
    LEITNER, T
    ESCANILLA, D
    UHLEN, M
    JOURNAL OF VIROLOGY, 1994, 68 (09) : 5918 - 5924
  • [29] Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2gag peptide
    Misumi, S
    Morikawa, Y
    Tomonaga, M
    Ohkuma, K
    Takamune, N
    Shoji, S
    JOURNAL OF BIOCHEMISTRY, 2004, 135 (03): : 447 - 453
  • [30] N-MYRISTYLATION OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 GAG POLYPROTEIN PRECURSOR IN SACCHAROMYCES-CEREVISIAE
    BATHURST, IC
    CHESTER, N
    GIBSON, HL
    DENNIS, AF
    STEIMER, KS
    BARR, PJ
    JOURNAL OF VIROLOGY, 1989, 63 (07) : 3176 - 3179